Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis
- PMID: 39694204
- DOI: 10.1016/j.cgh.2024.11.019
Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis
Abstract
Background & aims: Stage at diagnosis is a key prognostic factor for colorectal cancer (CRC) survival. We aimed to assess the global distribution of CRC staging at diagnosis using population-based or hospital-based registry data.
Methods: We systematically searched in MEDLINE and Embase from their inception until December 6, 2023. Gray literature was searched through published cancer reports. Studies from population-based or hospital-based cancer registries reporting the stage distribution of diagnosed CRC were included. We extracted stage-specific proportions among patients with CRC based on TNM; Surveillance, Epidemiology, and End Results; or Dukes staging systems. Subgroup analyses by sex, age, tumor site, calendar period, and status of population-based screening were performed. Correlations between the Human Development Index (HDI), Socio-Demographic Index (SDI), and the distant metastatic CRC proportion were also evaluated.
Results: A total of 84 eligible studies/reports from 46 countries were analyzed, covering 3.8 million patients. Among 36 countries included in the main analysis, the most recent distant metastatic CRC proportions varied from 16.2% in Puerto Rico to 28.2% in Oman and Latvia, with a median of 23.7% (interquartile range, 21.8%-26.3%). Higher metastatic proportions were observed in younger patients, those with colon cancer, and those without screening implementation, with no apparent difference between males and females. Over time, some countries/regions, such as Southern Portugal (36.5% in 2000 to 22.2% in 2016), showed declining proportions of metastatic CRC, whereas others remained stable (eg, Austria, Belgium) or increased (eg, United States, Slovenia, Spain). Higher HDI and SDI were correlated with lower proportions of distant metastatic CRC (HDI: ρ = -0.48; SDI: ρ = -0.26).
Conclusion: Global disparities in CRC staging exist, indicating a need for targeted interventions to enhance early detection and management, especially in high-metastasis areas.
Keywords: Colorectal Cancer; Stage; Systematic Review.
Copyright © 2025. Published by Elsevier Inc.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.Int J Cancer. 2024 Jul 1;155(1):54-60. doi: 10.1002/ijc.34895. Epub 2024 Mar 8. Int J Cancer. 2024. PMID: 38456478
-
Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.Lancet Gastroenterol Hepatol. 2022 Aug;7(8):711-723. doi: 10.1016/S2468-1253(22)00084-X. Epub 2022 May 11. Lancet Gastroenterol Hepatol. 2022. PMID: 35561739
-
Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location.Clin Gastroenterol Hepatol. 2021 May;19(5):955-966.e61. doi: 10.1016/j.cgh.2020.02.026. Epub 2020 Feb 21. Clin Gastroenterol Hepatol. 2021. PMID: 32088300
-
Management of Metastatic Colorectal Cancer in Pregnancy: A Systematic Review of a Multidisciplinary Challenge.Visc Med. 2025 Mar 28:1-11. doi: 10.1159/000545464. Online ahead of print. Visc Med. 2025. PMID: 40395620 Free PMC article. Review.
Cited by
-
A family with gallstone disease: defining inherited risk in the era of clinical genetic testing.Intern Emerg Med. 2025 Mar;20(2):509-514. doi: 10.1007/s11739-024-03854-7. Epub 2025 Jan 9. Intern Emerg Med. 2025. PMID: 39786488
-
Global disease burden of colorectal cancer attributable to high BMI has more than doubled over the past 30 years.Front Oncol. 2025 May 19;15:1580458. doi: 10.3389/fonc.2025.1580458. eCollection 2025. Front Oncol. 2025. PMID: 40463870 Free PMC article.
-
The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease.Hepatol Int. 2025 Apr;19(2):337-348. doi: 10.1007/s12072-025-10795-6. Epub 2025 Mar 26. Hepatol Int. 2025. PMID: 40140191 Free PMC article. Review.
-
An association between average daily sleep duration and gallstones in US adults.Sci Rep. 2025 Feb 7;15(1):4573. doi: 10.1038/s41598-025-89157-z. Sci Rep. 2025. PMID: 39915625 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources